Octagon Capital Advisors LP - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Dianthus Therapeutics, Inc. /DE/ (DNTH)

Filing Manager: Octagon Capital Advisors LP
Reporting Manager: Octagon Capital Advisors LP
Security: Dianthus Therapeutics, Inc. /DE/ Common Stock, $0.001 par value
Symbol: DNTH
Shares outstanding: 29.7M shares
Disclosed Ownership: 2.11M shares
Ownership: 7.1%
Form type: SCHEDULE 13G/A
Date filed: 2/5/2025, 05:42 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Octagon Capital Advisors LP	7.1%	2.11M	0	2.11M	/s/ Ting Jia	Managing Member
Octagon Investments Master Fund LP	6.1%	1.82M	0	1.82M	/s/ Ting Jia	Managing Member, Octagon Investments GP, LLC, its general partner
Octagon Private Opportunities Fund II LP	1%	292K	0	292K	/s/ Ting Jia	Managing Member, Octagon Investments GP, LLC, its general partner
Ting Jia	7.1%	2.11M	0	2.11M	/s/ Ting Jia	Ting Jia